| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Brandt Peter C. | Director | C/O IN8BIO, INC., 350 5TH AVE. SUITE 5330, NEW YORK | /s/ William Ho, Attorney-in-Fact | 23 Dec 2025 | 0001434099 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | INAB | Common Stock | Award | $100,000 | +72,464 | +319% | $1.38 | 95,181 | 22 Dec 2025 | Direct | F1 |
| holding | INAB | Common Stock | 3,509 | 22 Dec 2025 | See footnote | F1, F2 |
| Id | Content |
|---|---|
| F1 | Effective June 3, 2025, the Issuer effected a 1-for-30 reverse stock split of the Issuer's common stock. The number of securities reported herein have been adjusted to reflect the reverse stock split. |
| F2 | The securities are held by The Peter C. Brandt 2020-4 GRAT (the "GRAT"). The Reporting Person is the trustee of the GRAT and, as such, has voting and investment power over the shares held by the GRAT. |